Fielmann has established a multi-brand portfolio (Fielmann, Optika Clarus, SVS VISION, and others) enabling market penetration across different customer segments. The company is pursuing aggressive growth through both organic expansion and strategic acquisitions, demonstrating strong operational execution with double-digit revenue growth and margin expansion in recent years.
Cyborg Score Rationale
Fielmann demonstrates robust financial momentum with 15% sales growth to €2.3B and 23% profitability improvement in FY2024. The company has strong market positioning in vision care with healthy EBITDA margins (~20%) and is executing an international expansion strategy. However, retail sector headwinds and competitive pressures temper the outlook.
Top Insights
Strong FY2024 results with €2.3B revenue (+15%) and earnings growth of 23%, indicating operational leverage and scaling benefits
Strategic US market acquisitions driving international expansion beyond traditional European core markets